Prognostic implications of unrecognized myocardial infarction and periprocedural myocardial injury on cardiac magnetic resonance imaging in patients with chronic coronary syndrome.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 08 2023
21 08 2023
Historique:
received:
10
05
2023
accepted:
17
08
2023
medline:
23
8
2023
pubmed:
22
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
This study sought to evaluate the prognostic implications of the presence of preprocedural unrecognized myocardial infarction (UMI) and periprocedural myocardial injury (PMI) evaluated by delayed gadolinium enhancement cardiac magnetic resonance (DE-CMR) in patients with chronic coronary syndrome (CCS) undergoing elective percutaneous coronary intervention (PCI). We enrolled 250 CCS patients scheduled for elective PCI. UMI was defined as the presence of late gadolinium enhancement (LGE) detected by pre-PCI CMR in the region without medical history of revascularization and/or MI. Periprocedural new occurrence or increased volume of LGE in the target territory detected by post-PCI CMR (PPL) were used to assess PMI. In the final analysis of 235 patients, UMI and PPL were detected in 43 patients (18.3%) and 45 patients (19.1%), respectively. During follow-up for a median of 2.2 years, major adverse cardiac events (MACE) occurred in 31 (13.2%) patients. On multivariable analysis, UMI and PPL remained as significant predictors of MACE after adjusting confounding factors (HR 4.62, 95% CI 2.24-9.54, P < 0.001, HR 2.33, 95% CI 1.11-4.91, P = 0.026). In patients with CCS who underwent elective PCI, UMI and PPL were independent predictors of worse outcomes. UMI and PPL on DE-CMR might provide additional potential insight for the risk stratification of patients undergoing elective PCI.
Identifiants
pubmed: 37604987
doi: 10.1038/s41598-023-40883-2
pii: 10.1038/s41598-023-40883-2
pmc: PMC10442331
doi:
Substances chimiques
Contrast Media
0
Gadolinium
AU0V1LM3JT
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
13567Informations de copyright
© 2023. Springer Nature Limited.
Références
Eur Heart J. 2014 May;35(17):1101-11
pubmed: 24366916
J Cardiovasc Magn Reson. 2020 Mar 12;22(1):19
pubmed: 32160925
Eur Heart J. 2021 Jul 15;42(27):2630-2642
pubmed: 34059914
PLoS One. 2018 Jul 6;13(7):e0200381
pubmed: 29979788
Circ Cardiovasc Interv. 2010 Dec;3(6):602-10
pubmed: 21156928
N Engl J Med. 2020 Apr 9;382(15):1395-1407
pubmed: 32227755
Circ Cardiovasc Imaging. 2018 Jul;11(7):e007562
pubmed: 30012825
J Am Coll Cardiol. 2008 Aug 12;52(7):523-7
pubmed: 18687244
Circ Cardiovasc Interv. 2011 Oct 1;4(5):429-37
pubmed: 21972399
Circulation. 2000 Jun 13;101(23):2696-702
pubmed: 10851206
Circulation. 2013 Mar 5;127(9):980-7
pubmed: 23362315
J Am Coll Cardiol. 2016 Nov 29;68(21):2259-2268
pubmed: 27884243
JAMA Cardiol. 2018 Nov 1;3(11):1101-1106
pubmed: 30304454
J Am Coll Cardiol. 2020 Aug 25;76(8):945-957
pubmed: 32819469
Eur Heart J Cardiovasc Imaging. 2022 Jan 24;23(2):255-265
pubmed: 33280019
Am J Cardiol. 2014 Jan 1;113(1):1-6
pubmed: 24216125
Lancet. 2018 Mar 10;391(10124):939-948
pubmed: 29478841
Sci Rep. 2022 Dec 14;12(1):21579
pubmed: 36517567
JACC Cardiovasc Interv. 2014 Feb;7(2):195-201
pubmed: 24440015